Global Beta-lactam and Beta-lactamase Inhibitors Market Analysis 2015-2019 and Forecast 2020-2025
- 99S3755491
- 93 Pages
- February 2020
- Healthcare
The global Beta-lactam and Beta-lactamase Inhibitors market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Beta-lactam and Beta-lactamase Inhibitors by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Penicillin
Cephalosporin
Carbapenem
Monobactam
Combination
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Abbott Laboratories
Allergan Plc.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Merck & Co. Inc.
Mylan N.V.
Novartis International AG (Sandoz)
Pfizer Inc.
Sanofi
Teva Pharmaceutical Industries Ltd
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Oral
Intravenous
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Beta-lactam and Beta-lactamase Inhibitors Industry
Figure Beta-lactam and Beta-lactamase Inhibitors Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Beta-lactam and Beta-lactamase Inhibitors
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Beta-lactam and Beta-lactamase Inhibitors
1.2.2 Downstream
Table Application Segment of Beta-lactam and Beta-lactamase Inhibitors
Table Global Beta-lactam and Beta-lactamase Inhibitors Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Beta-lactam and Beta-lactamase Inhibitors Market by Type
3.1 By Type
3.1.1 Penicillin
Table Major Company List of Penicillin
3.1.2 Cephalosporin
Table Major Company List of Cephalosporin
3.1.3 Carbapenem
Table Major Company List of Carbapenem
3.1.4 Monobactam
Table Major Company List of Monobactam
3.1.5 Combination
Table Major Company List of Combination
3.2 Market Size
Table Global Beta-lactam and Beta-lactamase Inhibitors Market 2015-2019, by Type, in USD Million
Figure Global Beta-lactam and Beta-lactamase Inhibitors Market Growth 2015-2019, by Type, in USD Million
Table Global Beta-lactam and Beta-lactamase Inhibitors Market 2015-2019, by Type, in Volume
Figure Global Beta-lactam and Beta-lactamase Inhibitors Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Forecast 2020-2025, by Type, in USD Million
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Abbott Laboratories (Company Profile, Sales Data etc.)
4.1.1 Abbott Laboratories Profile
Table Abbott Laboratories Overview List
4.1.2 Abbott Laboratories Products & Services
4.1.3 Abbott Laboratories Business Operation Conditions
Table Business Operation of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Allergan Plc. (Company Profile, Sales Data etc.)
4.2.1 Allergan Plc. Profile
Table Allergan Plc. Overview List
4.2.2 Allergan Plc. Products & Services
4.2.3 Allergan Plc. Business Operation Conditions
Table Business Operation of Allergan Plc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)
4.3.1 F. Hoffmann-La Roche Ltd. Profile
Table F. Hoffmann-La Roche Ltd. Overview List
4.3.2 F. Hoffmann-La Roche Ltd. Products & Services
4.3.3 F. Hoffmann-La Roche Ltd. Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 GlaxoSmithKline plc (Company Profile, Sales Data etc.)
4.4.1 GlaxoSmithKline plc Profile
Table GlaxoSmithKline plc Overview List
4.4.2 GlaxoSmithKline plc Products & Services
4.4.3 GlaxoSmithKline plc Business Operation Conditions
Table Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Merck & Co. Inc. (Company Profile, Sales Data etc.)
4.5.1 Merck & Co. Inc. Profile
Table Merck & Co. Inc. Overview List
4.5.2 Merck & Co. Inc. Products & Services
4.5.3 Merck & Co. Inc. Business Operation Conditions
Table Business Operation of Merck & Co. Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Mylan N.V. (Company Profile, Sales Data etc.)
4.6.1 Mylan N.V. Profile
Table Mylan N.V. Overview List
4.6.2 Mylan N.V. Products & Services
4.6.3 Mylan N.V. Business Operation Conditions
Table Business Operation of Mylan N.V. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Novartis International AG (Sandoz) (Company Profile, Sales Data etc.)
4.7.1 Novartis International AG (Sandoz) Profile
Table Novartis International AG (Sandoz) Overview List
4.7.2 Novartis International AG (Sandoz) Products & Services
4.7.3 Novartis International AG (Sandoz) Business Operation Conditions
Table Business Operation of Novartis International AG (Sandoz) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Pfizer Inc. (Company Profile, Sales Data etc.)
4.8.1 Pfizer Inc. Profile
Table Pfizer Inc. Overview List
4.8.2 Pfizer Inc. Products & Services
4.8.3 Pfizer Inc. Business Operation Conditions
Table Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Sanofi (Company Profile, Sales Data etc.)
4.9.1 Sanofi Profile
Table Sanofi Overview List
4.9.2 Sanofi Products & Services
4.9.3 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Teva Pharmaceutical Industries Ltd (Company Profile, Sales Data etc.)
4.10.1 Teva Pharmaceutical Industries Ltd Profile
Table Teva Pharmaceutical Industries Ltd Overview List
4.10.2 Teva Pharmaceutical Industries Ltd Products & Services
4.10.3 Teva Pharmaceutical Industries Ltd Business Operation Conditions
Table Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Beta-lactam and Beta-lactamase Inhibitors Sales Revenue 2015-2019, by Company, in USD Million
Table Global Beta-lactam and Beta-lactamase Inhibitors Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Beta-lactam and Beta-lactamase Inhibitors Sales Revenue Share in 2019, by Company, in USD Million
Table Global Beta-lactam and Beta-lactamase Inhibitors Sales Volume 2015-2019, by Company, in Volume
Table Global Beta-lactam and Beta-lactamase Inhibitors Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Beta-lactam and Beta-lactamase Inhibitors Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Beta-lactam and Beta-lactamase Inhibitors Market Concentration, in 2019
Figure Europe Beta-lactam and Beta-lactamase Inhibitors Market Market Concentration, in 2019
Figure Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors MMarket Concentration, in 2019
Figure South America Beta-lactam and Beta-lactamase Inhibitors Market Concentration, in 2019
Figure Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Oral
Figure Beta-lactam and Beta-lactamase Inhibitors Demand in Oral, 2015-2019, in USD Million
Figure Beta-lactam and Beta-lactamase Inhibitors Demand in Oral, 2015-2019, in Volume
6.1.2 Demand in Intravenous
Figure Beta-lactam and Beta-lactamase Inhibitors Demand in Intravenous, 2015-2019, in USD Million
Figure Beta-lactam and Beta-lactamase Inhibitors Demand in Intravenous, 2015-2019, in Volume
6.1.3 Demand in Others
Figure Beta-lactam and Beta-lactamase Inhibitors Demand in Others, 2015-2019, in USD Million
Figure Beta-lactam and Beta-lactamase Inhibitors Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Beta-lactam and Beta-lactamase Inhibitors Demand Forecast 2020-2025, by Application, in USD Million
Figure Beta-lactam and Beta-lactamase Inhibitors Market Growth 2020-2025, by Application, in USD Million
Figure Beta-lactam and Beta-lactamase Inhibitors Market Share in 2025, by Application, in USD Million
Table Beta-lactam and Beta-lactamase Inhibitors Demand Forecast 2020-2025, by Application, in Volume
Table Beta-lactam and Beta-lactamase Inhibitors Market Growth 2020-2025, by Application, in Volume
Table Beta-lactam and Beta-lactamase Inhibitors Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Beta-lactam and Beta-lactamase Inhibitors Production 2015-2019, by Region, in USD Million
Table Beta-lactam and Beta-lactamase Inhibitors Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Beta-lactam and Beta-lactamase Inhibitors Market 2015-2019, by Region, in USD Million
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Share 2015-2019, by Region, in USD Million
Table Global Beta-lactam and Beta-lactamase Inhibitors Market 2015-2019, by Region, in Volume
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Beta-lactam and Beta-lactamase Inhibitors Market Size and Growth 2015-2019, in USD Million
Figure North America Beta-lactam and Beta-lactamase Inhibitors Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Beta-lactam and Beta-lactamase Inhibitors Market Size 2015-2019, by Country, in USD Million
Table North America Beta-lactam and Beta-lactamase Inhibitors Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Beta-lactam and Beta-lactamase Inhibitors Market Size and Growth 2015-2019, in USD Million
Figure Europe Beta-lactam and Beta-lactamase Inhibitors Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Beta-lactam and Beta-lactamase Inhibitors Market Size 2015-2019, by Country, in USD Million
Table Europe Beta-lactam and Beta-lactamase Inhibitors Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Beta-lactam and Beta-lactamase Inhibitors Market Size and Growth 2015-2019, in USD Million
Figure South America Beta-lactam and Beta-lactamase Inhibitors Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Beta-lactam and Beta-lactamase Inhibitors Market Size 2015-2019, by Country, in USD Million
Table South America Beta-lactam and Beta-lactamase Inhibitors Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Beta-lactam and Beta-lactamase Inhibitors Market Forecast 2020-2025, by Region, in USD Million
Table Beta-lactam and Beta-lactamase Inhibitors Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
Table Upstream Segment of Beta-lactam and Beta-lactamase Inhibitors
Table Application Segment of Beta-lactam and Beta-lactamase Inhibitors
Table Global Beta-lactam and Beta-lactamase Inhibitors Market 2015-2025, by Application, in USD Million
Table Major Company List of Cephalosporin
Table Major Company List of Carbapenem
Table Major Company List of Monobactam
Table Major Company List of Combination
Table Global Beta-lactam and Beta-lactamase Inhibitors Market 2015-2019, by Type, in USD Million
Table Global Beta-lactam and Beta-lactamase Inhibitors Market 2015-2019, by Type, in Volume
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Forecast 2020-2025, by Type, in USD Million
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Forecast 2020-2025, by Type, in Volume
Table Abbott Laboratories Overview List
Table Business Operation of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergan Plc. Overview List
Table Business Operation of Allergan Plc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche Ltd. Overview List
Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline plc Overview List
Table Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co. Inc. Overview List
Table Business Operation of Merck & Co. Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan N.V. Overview List
Table Business Operation of Mylan N.V. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis International AG (Sandoz) Overview List
Table Business Operation of Novartis International AG (Sandoz) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Inc. Overview List
Table Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Industries Ltd Overview List
Table Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Beta-lactam and Beta-lactamase Inhibitors Sales Revenue 2015-2019, by Company, in USD Million
Table Global Beta-lactam and Beta-lactamase Inhibitors Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Beta-lactam and Beta-lactamase Inhibitors Sales Volume 2015-2019, by Company, in Volume
Table Global Beta-lactam and Beta-lactamase Inhibitors Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Beta-lactam and Beta-lactamase Inhibitors Demand Forecast 2020-2025, by Application, in USD Million
Table Beta-lactam and Beta-lactamase Inhibitors Demand Forecast 2020-2025, by Application, in Volume
Table Beta-lactam and Beta-lactamase Inhibitors Market Growth 2020-2025, by Application, in Volume
Table Beta-lactam and Beta-lactamase Inhibitors Market Share in 2025, by Application, in Volume
Table Beta-lactam and Beta-lactamase Inhibitors Production 2015-2019, by Region, in USD Million
Table Beta-lactam and Beta-lactamase Inhibitors Production 2015-2019, by Region, in Volume
Table Global Beta-lactam and Beta-lactamase Inhibitors Market 2015-2019, by Region, in USD Million
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Share 2015-2019, by Region, in USD Million
Table Global Beta-lactam and Beta-lactamase Inhibitors Market 2015-2019, by Region, in Volume
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Share 2015-2019, by Region, in Volume
Table North America Beta-lactam and Beta-lactamase Inhibitors Market Size 2015-2019, by Country, in USD Million
Table North America Beta-lactam and Beta-lactamase Inhibitors Market Size 2015-2019, by Country, in Volume
Table Europe Beta-lactam and Beta-lactamase Inhibitors Market Size 2015-2019, by Country, in USD Million
Table Europe Beta-lactam and Beta-lactamase Inhibitors Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size 2015-2019, by Country, in Volume
Table South America Beta-lactam and Beta-lactamase Inhibitors Market Size 2015-2019, by Country, in USD Million
Table South America Beta-lactam and Beta-lactamase Inhibitors Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size 2015-2019, by Country, in Volume
Table Beta-lactam and Beta-lactamase Inhibitors Market Forecast 2020-2025, by Region, in USD Million
Table Beta-lactam and Beta-lactamase Inhibitors Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
